Latest Articles

Publication Date
Overall Survival After Hormonal Therapy vs Hysterectomy in Early Endometrial Cancer - The ASCO Post

Overall Survival After Hormonal Therapy vs Hysterectomy in Early Endometrial Cancer The ASCO Post

Published: Sept. 19, 2025, 2:31 p.m.
Adjuvant Chemoradiotherapy vs Radiotherapy for High-Risk Endometrial Cancer: 10-Year PORTEC-3 Outcomes - The ASCO Post

Adjuvant Chemoradiotherapy vs Radiotherapy for High-Risk Endometrial Cancer: 10-Year PORTEC-3 Outcomes The ASCO Post

Published: Sept. 19, 2025, 2:23 p.m.
Cartherics awarded at 2025 Asia Pacific Cell & Gene Therapy Excellence Awards - BioMelbourne Network

Cartherics awarded at 2025 Asia Pacific Cell & Gene Therapy Excellence Awards BioMelbourne Network

Published: Sept. 15, 2025, 5:03 a.m.
Cartherics Wins ‘Most Promising iPSC Therapy Pipeline in APAC’ at Asia Pacific Cell & Gene Therapy Excellence Awards - BioInformant

Cartherics Wins ‘Most Promising iPSC Therapy Pipeline in APAC’ at Asia Pacific Cell & Gene Therapy Excellence Awards BioInformant

Published: Sept. 13, 2025, 9:33 a.m.
FOXA2 sensitizes endometrial carcinoma to progestin-mediated conservative therapy by triggering PR transcriptional activation - Nature

FOXA2 sensitizes endometrial carcinoma to progestin-mediated conservative therapy by triggering PR transcriptional activation Nature

Published: Sept. 13, 2025, 5:58 a.m.
Specialty Influences Postcancer Hormone Therapy Prescribing - Medscape

Specialty Influences Postcancer Hormone Therapy Prescribing Medscape

Published: Sept. 11, 2025, 1:07 p.m.
Cartherics wins APAC Award for most promising iPSC therapy pipeline - Biotech Dispatch

Cartherics wins APAC Award for most promising iPSC therapy pipeline Biotech Dispatch

Published: Sept. 11, 2025, 12:46 a.m.
Endometrial cancer drug Rina-S wins FDA's breakthrough therapy designation - Rare Cancer News

Endometrial cancer drug Rina-S wins FDA's breakthrough therapy designation Rare Cancer News

Published: Sept. 10, 2025, 12:49 p.m.
New Illinois law restricts the use of AI in psychotherapy - marketplace.org

New Illinois law restricts the use of AI in psychotherapy marketplace.org

Published: Sept. 2, 2025, 3:15 p.m.
Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 as Demand for Hormone Therapy Accelerates – SNS Insider - SINA HONG KONG LIMITED

Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 as Demand for Hormone Therapy Accelerates – SNS Insider SINA HONG KONG LIMITED

Published: Sept. 2, 2025, 11:40 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!